May 29, 2024 — Congenital heart disease (CHD) is one of the most common congenital anomalies worldwide, which brings a heavy health and financial burden to patients. Early CHD screening and treatment can significantly improve children’s prognosis and quality of life.

May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC).1

May 24, 2024 — The American Heart Association has issued a statement warning that false information about COVID vaccination and heart defects attributed to the Association may be spreading. The misinformation is inaccurately and incorrectly connected to a recent scientific paper on cardiovascular-kidney-metabolic (CKM) syndrome.

May 24, 2024 — Lexicon Pharmaceuticals, Inc. announced a new post-hoc analysis of clinical data showing that INPEFA (sotagliflozin), a dual oral inhibitor of SGLT2 and SGLT1, reduced the risk of heart failure-related events across a diverse population of patients, including patients with preserved ejection fraction (

May 24, 2024 — An artificial intelligence (AI) program developed by investigators in the 

May 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, announced that the data from its REVEALPLAQUE study, highlighting the accuracy of its Plaque Analysis, was 

May 23, 2024 — Global Heart Hub, the international alliance of heart patient organizations, announced the first findings from their patient-led Insights from Patients living with Elevated Cholesterol (IPEC) data generation program.

May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical Center, The University of Texas at Tyler and University of Alabama at Birmingham, shows that exercising, even at very high levels, is not related to the progression of coronary artery calcium (CAC), a marker of atherosclerotic cardiovascular disease.

May 22, 2024 — Voiant (USA) and Thirona (The Netherlands) announced they have entered a global commercial partnership, combining Voiant's expertise in supporting clinical trials in pulmonary drug and treatment development with Thirona's expertise in advanced lung im

May 23, 2024 — A newly-published peer-reviewed study in the Journal of the American Heart Association, JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now